$2.05
-0.05-2.15%
At Close: -
15 minutes delayed
Comments
Loading...
NervGen Pharma
NGENFOTCQB
NervGen Pharma (NGENF) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNervGen Pharma (OTC:NGENF) Stock Quotes, Forecast and News Summary
NervGen Pharma Stock (OTC: NGENF) stock price, news, charts, stock research, profile.
| Open | $2.11 |
| Close | $2.05 |
| Volume / Avg. | 34.80K / 80.03K |
| Day Range | 2.04 - 2.11 |
| 52 Wk Range | 1.16 - 2.99 |
| Market Cap | $143.35M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | OTC |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | 1.71 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
NervGen Pharma Corp principal business activity is the discovery, development, and commercialization...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NervGen Pharma (NGENF) stock?
You can purchase shares of NervGen Pharma (OTCQB:NGENF) through any online brokerage.
Who are NervGen Pharma (NGENF) competitors?
There are no as such competitors for NervGen Pharma.
What is the target price for NervGen Pharma (NGENF) stock?
There is no analysis for NervGen Pharma.
What is the forecast for NervGen Pharma (NGENF) stock?
There is no analysis for NervGen Pharma to provide a consensus price target.
Current stock price for NervGen Pharma (NGENF)?
The stock price for NervGen Pharma (OTCQB: NGENF) is $2.05 last updated July 25, 2024 at 3:59 PM EDT.
Does NervGen Pharma (NGENF) pay a dividend?
There are no upcoming dividends for NervGen Pharma.
When is NervGen Pharma (OTCQB:NGENF) reporting earnings?
NervGen Pharma does not have any upcoming earnings scheduled.
Is NervGen Pharma (NGENF) going to split?
There is no upcoming split for NervGen Pharma.
What sector and industry does NervGen Pharma (NGENF) operate in?
NervGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.